Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adding a low dose atypical antipsychotic drug to an antidepressant induced a rapid increase of plasma brain-derived neurotrophic factor levels in patients with treatment-resistant depression.
Yoshimura R, Ikenouchi-Sugita A, Hori H, Umene-Nakano W, Katsuki A, Hayashi K, Ueda N, Nakamura J. Yoshimura R, et al. Among authors: nakamura j. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Mar 17;34(2):308-12. doi: 10.1016/j.pnpbp.2009.12.003. Epub 2009 Dec 11. Prog Neuropsychopharmacol Biol Psychiatry. 2010. PMID: 20005280
Risperidone in the treatment of psychotic depression.
Goto M, Yoshimura R, Kakihara S, Shinkai K, Yamada Y, Kaji K, Ueda N, Nakamura J. Goto M, et al. Among authors: nakamura j. Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jun;30(4):701-7. doi: 10.1016/j.pnpbp.2006.01.016. Epub 2006 Mar 6. Prog Neuropsychopharmacol Biol Psychiatry. 2006. PMID: 16580110 Clinical Trial.
Plasma levels of brain derived-neurotrophic factor and catecholamine metabolites are increased during active phase of psychotic symptoms in CNS lupus: a case report.
Ikenouchi A, Yoshimura R, Ikemura N, Utsunomiya K, Mitoma M, Nakamura J. Ikenouchi A, et al. Among authors: nakamura j. Prog Neuropsychopharmacol Biol Psychiatry. 2006 Sep 30;30(7):1359-63. doi: 10.1016/j.pnpbp.2006.03.006. Epub 2006 Apr 19. Prog Neuropsychopharmacol Biol Psychiatry. 2006. PMID: 16626841
Successful treatment for obsessive-compulsive disorder with addition of low-dose risperidone to fluvoxamine: implications for plasma levels of catecholamine metabolites and serum brain-derived neurotrophic factor levels.
Yoshimura R, Kaneko S, Shinkai K, Nakamura J. Yoshimura R, et al. Among authors: nakamura j. Psychiatry Clin Neurosci. 2006 Jun;60(3):389-93. doi: 10.1111/j.1440-1819.2006.01519.x. Psychiatry Clin Neurosci. 2006. PMID: 16732759 Free article.
Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients.
Yoshimura R, Hori H, Sugita A, Ueda N, Kakihara S, Umene W, Nakano Y, Shinkai K, Mitoma M, Ohta M, Shinkai T, Nakamura J. Yoshimura R, et al. Among authors: nakamura j. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1072-7. doi: 10.1016/j.pnpbp.2007.03.010. Epub 2007 Mar 24. Prog Neuropsychopharmacol Biol Psychiatry. 2007. PMID: 17459549
2,195 results